158 related articles for article (PubMed ID: 23298809)
1. Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency.
Bollini M; Gallardo-Macias R; Spasov KA; Tirado-Rives J; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2013 Feb; 23(4):1110-3. PubMed ID: 23298809
[TBL] [Abstract][Full Text] [Related]
2. Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.
Frey KM; Puleo DE; Spasov KA; Bollini M; Jorgensen WL; Anderson KS
J Med Chem; 2015 Mar; 58(6):2737-45. PubMed ID: 25700160
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided discovery of anti-HIV agents.
Jorgensen WL
Bioorg Med Chem; 2016 Oct; 24(20):4768-4778. PubMed ID: 27485603
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
Kang D; Fang Z; Huang B; Lu X; Zhang H; Xu H; Huo Z; Zhou Z; Yu Z; Meng Q; Wu G; Ding X; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2017 May; 60(10):4424-4443. PubMed ID: 28481112
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor.
Dousson C; Alexandre FR; Amador A; Bonaric S; Bot S; Caillet C; Convard T; da Costa D; Lioure MP; Roland A; Rosinovsky E; Maldonado S; Parsy C; Trochet C; Storer R; Stewart A; Wang J; Mayes BA; Musiu C; Poddesu B; Vargiu L; Liuzzi M; Moussa A; Jakubik J; Hubbard L; Seifer M; Standring D
J Med Chem; 2016 Mar; 59(5):1891-8. PubMed ID: 26804933
[TBL] [Abstract][Full Text] [Related]
8. Development of nonnucleoside HIV reverse transcriptase inhibitors.
Tucker TJ; Lumma WC; Culberson JC
Methods Enzymol; 1996; 275():440-72. PubMed ID: 9026654
[No Abstract] [Full Text] [Related]
9. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
10. Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.
Jorgensen WL; Bollini M; Thakur VV; Domaoal RA; Spasov KA; Anderson KS
J Am Chem Soc; 2011 Oct; 133(39):15686-96. PubMed ID: 21853995
[TBL] [Abstract][Full Text] [Related]
11. Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase.
Lee WG; Frey KM; Gallardo-Macias R; Spasov KA; Chan AH; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2015 Nov; 25(21):4824-4827. PubMed ID: 26166629
[TBL] [Abstract][Full Text] [Related]
12. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Sang Y; Pannecouque C; De Clercq E; Zhuang C; Chen F
Bioorg Chem; 2020 Mar; 96():103595. PubMed ID: 32006797
[TBL] [Abstract][Full Text] [Related]
14. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Kim JT; Hamilton AD; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
J Am Chem Soc; 2006 Dec; 128(48):15372-3. PubMed ID: 17131993
[TBL] [Abstract][Full Text] [Related]
15. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
16. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants.
Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G
ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401
[No Abstract] [Full Text] [Related]
17. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
18. Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy.
Zeng ZS; He QQ; Liang YH; Feng XQ; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Bioorg Med Chem; 2010 Jul; 18(14):5039-47. PubMed ID: 20598556
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
[TBL] [Abstract][Full Text] [Related]
20. Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.
Frączek T; Kamiński R; Krakowiak A; Naessens E; Verhasselt B; Paneth P
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):9-16. PubMed ID: 29098886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]